Frovatriptan Market Opportunities 2031
Frovatriptan is a drug belonging to triptan category developed for migraine headache and menstruation related migraine. Frovatriptan is taken by oral route with or without food but it shows very good results when taken before food. Frovatriptan inhibits excessive dilation of arteries that supply blood to head. Some adverse effects of frovatriptan are, dizziness, myocardial infarction, ventricular tachycardia, numbness and dry mouth.
MARKET DYNAMICS
The key market drivers for Frovatriptan Market are, increasing prevalence of migraine, menstruation pain along with rising geriatric population across the globe. Moreover, high R&D investments by pharmaceutical companies to develop novel drug therapies for effective management of diseases is also expected to boost market growth during forecast period. However, few side effects associated with the drug may restrict market growth during forecast period.
MARKET SCOPE
The "Frovatriptan Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Frovatriptan market with detailed market segmentation by product and application. The Frovatriptan Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Frovatriptan Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Frovatriptan Market is segmented on the basis of product and application. On the basis of product the market is segmented as, tablet, capsule and others. And on the basis of application the market is bifurcated as, menstrual migraines, migraine with aura and migraine without aura.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Frovatriptan Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Frovatriptan Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Frovatriptan Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Frovatriptan Market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Frovatriptan Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Frovatriptan Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Frovatriptan Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Frovatriptan Market in these regions.
MARKET PLAYERS
The report covers key developments in the Frovatriptan Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Frovatriptan Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Frovatriptan market in the global market. Below mentioned is the list of few companies engaged in the Frovatriptan Market.
The report also includes the profiles of key players in Frovatriptan Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Ligand Pharmaceuticals
- Endo Pharmaceuticals
- Doc Generici
- Menarini
- Novartis
- Almac
- Glenmark
- Teva Pharmaceuticals
- Zambon
- Apotex
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Frovatriptan Market - By Product
1.3.2 Frovatriptan Market - By Application
1.3.3 Frovatriptan Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. FROVATRIPTAN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. FROVATRIPTAN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. FROVATRIPTAN MARKET - GLOBAL MARKET ANALYSIS
6.1. FROVATRIPTAN - GLOBAL MARKET OVERVIEW
6.2. FROVATRIPTAN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. FROVATRIPTAN MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. TABLET
7.3.1. Overview
7.3.2. Tablet Market Forecast and Analysis
7.4. CAPSULE
7.4.1. Overview
7.4.2. Capsule Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. FROVATRIPTAN MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. MENSTRUAL MIGRAINES
8.3.1. Overview
8.3.2. Menstrual Migraines Market Forecast and Analysis
8.4. MIGRAINE WITH AURA
8.4.1. Overview
8.4.2. Migraine with Aura Market Forecast and Analysis
8.5. MIGRAINE WITHOUT AURA
8.5.1. Overview
8.5.2. Migraine without Aura Market Forecast and Analysis
9. FROVATRIPTAN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Frovatriptan Market Overview
9.1.2 North America Frovatriptan Market Forecasts and Analysis
9.1.3 North America Frovatriptan Market Forecasts and Analysis - By Product
9.1.4 North America Frovatriptan Market Forecasts and Analysis - By Application
9.1.5 North America Frovatriptan Market Forecasts and Analysis - By Countries
9.1.5.1 United States Frovatriptan Market
9.1.5.1.1 United States Frovatriptan Market by Product
9.1.5.1.2 United States Frovatriptan Market by Application
9.1.5.2 Canada Frovatriptan Market
9.1.5.2.1 Canada Frovatriptan Market by Product
9.1.5.2.2 Canada Frovatriptan Market by Application
9.1.5.3 Mexico Frovatriptan Market
9.1.5.3.1 Mexico Frovatriptan Market by Product
9.1.5.3.2 Mexico Frovatriptan Market by Application
9.2. EUROPE
9.2.1 Europe Frovatriptan Market Overview
9.2.2 Europe Frovatriptan Market Forecasts and Analysis
9.2.3 Europe Frovatriptan Market Forecasts and Analysis - By Product
9.2.4 Europe Frovatriptan Market Forecasts and Analysis - By Application
9.2.5 Europe Frovatriptan Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Frovatriptan Market
9.2.5.1.1 Germany Frovatriptan Market by Product
9.2.5.1.2 Germany Frovatriptan Market by Application
9.2.5.2 France Frovatriptan Market
9.2.5.2.1 France Frovatriptan Market by Product
9.2.5.2.2 France Frovatriptan Market by Application
9.2.5.3 Italy Frovatriptan Market
9.2.5.3.1 Italy Frovatriptan Market by Product
9.2.5.3.2 Italy Frovatriptan Market by Application
9.2.5.4 Spain Frovatriptan Market
9.2.5.4.1 Spain Frovatriptan Market by Product
9.2.5.4.2 Spain Frovatriptan Market by Application
9.2.5.5 United Kingdom Frovatriptan Market
9.2.5.5.1 United Kingdom Frovatriptan Market by Product
9.2.5.5.2 United Kingdom Frovatriptan Market by Application
9.2.5.6 Rest of Europe Frovatriptan Market
9.2.5.6.1 Rest of Europe Frovatriptan Market by Product
9.2.5.6.2 Rest of Europe Frovatriptan Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Frovatriptan Market Overview
9.3.2 Asia-Pacific Frovatriptan Market Forecasts and Analysis
9.3.3 Asia-Pacific Frovatriptan Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Frovatriptan Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Frovatriptan Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Frovatriptan Market
9.3.5.1.1 Australia Frovatriptan Market by Product
9.3.5.1.2 Australia Frovatriptan Market by Application
9.3.5.2 China Frovatriptan Market
9.3.5.2.1 China Frovatriptan Market by Product
9.3.5.2.2 China Frovatriptan Market by Application
9.3.5.3 India Frovatriptan Market
9.3.5.3.1 India Frovatriptan Market by Product
9.3.5.3.2 India Frovatriptan Market by Application
9.3.5.4 Japan Frovatriptan Market
9.3.5.4.1 Japan Frovatriptan Market by Product
9.3.5.4.2 Japan Frovatriptan Market by Application
9.3.5.5 South Korea Frovatriptan Market
9.3.5.5.1 South Korea Frovatriptan Market by Product
9.3.5.5.2 South Korea Frovatriptan Market by Application
9.3.5.6 Rest of Asia-Pacific Frovatriptan Market
9.3.5.6.1 Rest of Asia-Pacific Frovatriptan Market by Product
9.3.5.6.2 Rest of Asia-Pacific Frovatriptan Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Frovatriptan Market Overview
9.4.2 Middle East and Africa Frovatriptan Market Forecasts and Analysis
9.4.3 Middle East and Africa Frovatriptan Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Frovatriptan Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Frovatriptan Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Frovatriptan Market
9.4.5.1.1 South Africa Frovatriptan Market by Product
9.4.5.1.2 South Africa Frovatriptan Market by Application
9.4.5.2 Saudi Arabia Frovatriptan Market
9.4.5.2.1 Saudi Arabia Frovatriptan Market by Product
9.4.5.2.2 Saudi Arabia Frovatriptan Market by Application
9.4.5.3 U.A.E Frovatriptan Market
9.4.5.3.1 U.A.E Frovatriptan Market by Product
9.4.5.3.2 U.A.E Frovatriptan Market by Application
9.4.5.4 Rest of Middle East and Africa Frovatriptan Market
9.4.5.4.1 Rest of Middle East and Africa Frovatriptan Market by Product
9.4.5.4.2 Rest of Middle East and Africa Frovatriptan Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Frovatriptan Market Overview
9.5.2 South and Central America Frovatriptan Market Forecasts and Analysis
9.5.3 South and Central America Frovatriptan Market Forecasts and Analysis - By Product
9.5.4 South and Central America Frovatriptan Market Forecasts and Analysis - By Application
9.5.5 South and Central America Frovatriptan Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Frovatriptan Market
9.5.5.1.1 Brazil Frovatriptan Market by Product
9.5.5.1.2 Brazil Frovatriptan Market by Application
9.5.5.2 Argentina Frovatriptan Market
9.5.5.2.1 Argentina Frovatriptan Market by Product
9.5.5.2.2 Argentina Frovatriptan Market by Application
9.5.5.3 Rest of South and Central America Frovatriptan Market
9.5.5.3.1 Rest of South and Central America Frovatriptan Market by Product
9.5.5.3.2 Rest of South and Central America Frovatriptan Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. FROVATRIPTAN MARKET, KEY COMPANY PROFILES
11.1. LIGAND PHARMACEUTICALS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ENDO PHARMACEUTICALS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. DOC GENERICI
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MENARINI
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVARTIS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ALMAC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLENMARK
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TEVA PHARMACEUTICALS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ZAMBON
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. APOTEX
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
11.11. G.L. PHARMA GMBH
11.11.1. Key Facts
11.11.2. Business Description
11.11.3. Products and Services
11.11.4. Financial Overview
11.11.5. SWOT Analysis
11.11.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Ligand Pharmaceuticals
2. Endo Pharmaceuticals
3. Doc Generici
4. Menarini
5. Novartis
6. Almac
7. Glenmark
8. Teva Pharmaceuticals
9. Zambon
10. Apotex
11. G.L. Pharma Gmbh
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For